Jinxin Fertility Group (HKG:1951) resolved to buy back up to HK$100 million of shares from the open market from time to time, a Monday Hong Kong bourse filing said.
Shares of the in-vitro fertilization company were up nearly 2% in Tuesday afternoon trading.